Trinity Health - Company Profile
Powered by
All the data and insights you need on Trinity Health in one report.
- Save hours of research time and resources with
our up-to-date Trinity Health Strategy Report
- Understand Trinity Health position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Trinity Health Catalyst Calendar
Proactively evaluate Trinity Health’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Trinity Health Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 May 2022 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
01 Jan 2022 | Phase II Trial Completion | Loyola University Health System | - | azacitidine; valproic acid | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Myelodysplastic Syndrome | Clinical Trial Registry |
15 Jul 2021 | Phase IV Trial Initiation | Alden Network; Boston BioPharm; Brookdale Senior Living Inc; Corridor Mobile Medical Services; HealthTrackRx Inc; Nexion Health Inc; Optimum Health Services Corp; Priority Healthcare Corp; Remarkable Healthcare; Siemens AG; Summit Health; Telos Healthcare LLC; Trinity Health | BKD; SIE | Coronavirus Disease 2019 (COVID-19) Vaccine 1; elasomeran; tozinameran | Infectious Disease | Coronavirus Disease 2019 (COVID-19) | Clinical Trial Registry |
25 Mar 2021 | Phase II Trial Completion | Saint Francis Hospital and Medical Center | - | ascorbic acid; thiamine | Cardiovascular; Infectious Disease | Sepsis; Septic Shock | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer